Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

5.2K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Focal Therapy for Prostate Cancer: A Treatment Option Reserved for the Ideal Candi-date?

International braz j urol : official journal of the Brazilian Society of Urology·2026
Same author

ProBIOPSY: A Multidisciplinary International Consensus on Standards for Prostate Biopsy.

European urology·2026
Same author

Evidence Thresholds for Novel Therapeutic Strategies in Prostate Cancer: A Consensus Statement from the Prostate Cancer Committee of the French Urological Association.

The French journal of urology·2026
Same author

Shifting risk profile in radical prostatectomy over 18 years: A bicentric French study of 8,358 patients.

The French journal of urology·2026
Same author

Evaluation of dietary iron exposure across iron compounds and fortification levels in Saudi Arabia: simulation modeling study.

BMC nutrition·2026
Same author

One-year Follow-up after US-guided Transperineal Focal Laser Ablation of Localized Prostate Cancer: Worldwide Registry Study.

Radiology·2026

Related Experiment Video

Updated: Feb 20, 2026

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

9.5K

Biochemical recurrence after radical prostatectomy: what does it mean?

Rafael Tourinho-Barbosa1,2, Victor Srougi1,3, Igor Nunes-Silva1

  • 1Department of Urology, Institut Montsouris, Université Paris-Descartes, Paris, France.

International Braz J Urol : Official Journal of the Brazilian Society of Urology
|October 18, 2017
PubMed
Summary

Radical prostatectomy (RP) for prostate cancer (PCa) can lead to biochemical recurrence (BCR) in 20-40% of patients. Understanding BCR, its clinical impact, and risk factors is crucial for effective treatment strategies.

Keywords:
Prostate-Specific AntigenProstatectomyProstatic Neoplasms

More Related Videos

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

17.2K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.9K

Related Experiment Videos

Last Updated: Feb 20, 2026

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

9.5K
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

17.2K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.9K

Area of Science:

  • Urology
  • Oncology

Background:

  • Radical prostatectomy (RP) is a primary treatment for prostate cancer (PCa), yet 20-40% of patients experience biochemical recurrence (BCR).
  • Prostate-specific antigen (PSA) is key for diagnosing BCR, but consensus on the optimal PSA threshold is lacking.
  • The natural history of BCR post-RP varies, necessitating differentiation between biochemical and clinical recurrence for timely multimodal treatment.

Purpose of the Study:

  • To update the assessment of BCR definition and its implications.
  • To clarify the natural history of PCa post-BCR.
  • To evaluate the influence of clinical/pathological features and risk groups on BCR, metastasis, and cancer-specific mortality (CSM).

Main Methods:

  • A literature review was conducted using Medline.
  • Included English-language articles focused on biochemical recurrence after radical prostatectomy.

Main Results:

  • The review synthesizes current understanding of BCR definition and its prognostic significance.
  • It highlights the variability in PCa progression after BCR.
  • It examines the impact of various clinical and pathological factors on outcomes.

Conclusions:

  • Accurate BCR definition and understanding its natural history are vital.
  • Identifying prognostic factors aids in risk stratification and treatment planning.
  • Further research may refine BCR thresholds and optimize management strategies.